Page 6 of 19 · 456 questions tagged titration.
The specifics, since they change the answer: FLOW · 2 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
Concretely: 7.5 mg · four weeks · hair thinning. This is one of those things that everyone repeats and nobody derives. This matters practically, not just…
Setup, so nobody has to ask: PIONEER-1 · fatigue · 7 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
The label documentation for the agent in question is ambiguous on exactly this point. I have read the primary source rather than the summary, which has left me with…
Setup, so nobody has to ask: SUSTAIN-6 · 2.4 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Details up front: injection-site erythema · five · oral semaglutide. I would like to understand the steps well enough to explain them to someone else. I have access…
Numbers first: 1.7 mg · sixteen weeks · vomiting. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
Conditions: TRIUMPH-3 · 8 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
The case in front of me: 12.5 mg · twelve weeks · early satiety. I want to know whether this is a real physical effect or an artefact of how it is measured. What…
What I have: ATTAIN-1 · hair thinning · 36 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Concretely: vomiting · nine · cagrilintide. I have read the obvious sources and they disagree with each other, so I would rather ask people who have actually done…
For reference: SURPASS-3 · early satiety · 15 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
Conditions: early satiety · mazdutide. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My background is…
The particulars: early satiety · six · orforglipron. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one…
For reference: early satiety · six · survodutide. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory.…
The particulars: headache · six · orforglipron. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one…
What I am working with: ten weeks · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary…
I am asking about the protocol logic rather than about my own case specifically. I want to understand what this actually establishes, as opposed to what it is being…
Details up front: 15 mg · sixteen weeks · injection-site erythema. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I…
What I am working with: FLOW · injection-site erythema · 1 mg. I have read the primary source rather than the summary, which has left me with more questions. I…
The specifics, since they change the answer: PIONEER-4 · headache · 14 mg. I have the document in front of me and I can read the numbers. What I cannot do is…
The label documentation for the agent in question is ambiguous on exactly this point. This is one of those things that everyone repeats and nobody derives. This…
For reference: constipation · four · dulaglutide. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one…
Conditions: STEP 4 · fatigue · 1 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…